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The Increasing Burden of Mortality From Viral Hepatitis in the United States

TO THE EDITOR:
Although the data on mortality associated with hepatitis C virus (HCV) are certainly important to public health, Ly and colleagues (1) present them in a way that may lead to overestimation of HCV-related mortality. First, the authors define HCV death as having a death certificate mentioning HCV as either a contributing or an underlying cause. They do not present a breakdown of cause-specific mortality among these "HCV deaths." In our own analysis of HCV mortality, liver-related deaths represented only 20% of deaths in a large cohort of HCV-seropositive former blood donors (2) . Most mortality in our HCV cohort was related to trauma or suicide (23%), drug or alcohol use (14%), cardiovascular causes (13%), and cancer excluding hepatocellular carcinoma (12%). Ascertainment of HCV serostatus from blood donor records is probably more complete than from death certificates and therefore provides a more accurate estimate of attributable mortality than studies based on the latter method.
Second, in considering secular trends in HCV mortality, the authors do not mention the possible contribution of a birth cohort effect, which has been well-described for HCV infection (3, 4) . Because most persons infected with HCV in the United States probably acquired their infection from injection drug-related activity in the 1960s and 1970s, they constitute a cohort that is now aged 45 to 64 years. Therefore, it is reasonable that all-cause mortality will increase as this cohort ages, independent of a possible increase in HCVrelated liver mortality. Ly and colleagues could perform age-adjusted analyses to address this issue in their data.
Finally, the abstract states that "By 2007, HCV has superseded HIV as the cause of death in the United States . . . ," which gives the misleading impression that there is an epidemic of deaths from HCV. In fact, even with the loose definition of deaths from HCV that Ly and colleagues report, the rate is increasing gradually and the rate of deaths from HIV is decreasing, presumably owing to successful treatment of HIV disease, as the authors note. Although they are correct that deaths from HCV may be underestimated because of a lack of recording HCV status on the death certificate, that many HCV-infected persons die of causes unrelated to HCV may counterbalance this possible underestimation. Physicians treating these persons should be aware of potentially preventable, non-liver-related mortality due to trauma, suicide, and substance abuse. Dr. Murphy and colleagues analyzed a small sample of 453 HCV-infected blood donors who died between 1991 and 2002. This analysis was of only a single cause of death and found a very high rate of trauma and suicide in persons who died at an average age of 50 years (1). This does not seem to be a representative sample (2), and we think that comparing that study with ours is inappropriate. In any case, such deaths among HCV-infected blood donors would be subsumed in our analysis of all deaths of U.S. residents for the years of study. As indicated in Table 1 of our article, national death certificates indicate that 57% of decedents who had hepatitis C noted as an underlying or contributing cause of death also had a diagnosis of "chronic liver disease."
In answer to Dr. Murphy's question about a cohort effect, our analyses clearly indicated age-adjusted mortality rates in the text, figure, and tables.
We respectfully assert that there is indeed "an epidemic of deaths from HCV" in the United States, especially among baby boomers now aged 47 to 66 years. Rate increases only appear gradual because they are flattened by using a 100 000 person population as a denominator for the rates. More important, as we discussed, death certificates actually underenumerate HCV-related (or HBV-related) deaths because various studies now show that hepatitis C is diagnosed in half or fewer of patients before death. Even when patients are diagnosed, physicians and others filling out death certificates are often not the primary clinicians and may not be aware of the decedent's HCV infection.
We do agree that nonhepatic mortality among persons with HCV infection-including those with trauma, suicide, and substance abuse, as well as from effects of the virus on other organ systems-may not be adequately appreciated. 
